This analysis uncovers prognostic genes and the immune microenvironment in triple-negative breast cancer, suggesting new treatment avenues.
Immune-related genes (IRGs) play a pivotal role in the tumor microenvironment of triple-negative breast cancer (TNBC). This study aimed to uncover novel prognostic markers for TNBC based on IRGs. Differential expression analysis, univariate Cox regression, and machine learning algorithms identified BPI, GPHA2, KIR3DL3, MASP1, RASGRP1, and SEMA4A as potential prognostic genes. A random survival forest (RSF) model was developed and subsequently validated, alongside the creation of a prognostic nomogram to assess gene diagnostic performance. Further, epithelial cells, fibroblasts, and T cells were recognized as the primary cell types through which RASGRP1 exerts its effects. Finally, an analysis of the immune microenvironment and drug predictions provided fresh insights for the treatment of TNBC.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: